These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6657901)

  • 1. Myofascial syndrome: response to trigger-point injections.
    Hendler N; Fink H; Long D
    Psychosomatics; 1983 Nov; 24(11):990-9. PubMed ID: 6657901
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between newer local anesthetics for myofascial pain syndrome management.
    Zaralidou AT; Amaniti EN; Maidatsi PG; Gorgias NK; Vasilakos DF
    Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):353-7. PubMed ID: 17805438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain.
    Langford CF; Udvari Nagy S; Ghoniem GM
    Neurourol Urodyn; 2007; 26(1):59-62. PubMed ID: 17195176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occasional trigger point injection.
    Minty R; Kelly L; Minty A
    Can J Rural Med; 2007; 12(4):241-4. PubMed ID: 18076818
    [No Abstract]   [Full Text] [Related]  

  • 6. Electromyographically guided trigger point injections in the cervicothoracic musculature of obese patients: a new and unreported technique.
    Botwin KP; Patel BC
    Pain Physician; 2007 Nov; 10(6):753-6. PubMed ID: 17987097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy.
    Hameroff SR; Crago BR; Blitt CD; Womble J; Kanel J
    Anesth Analg; 1981 Oct; 60(10):752-5. PubMed ID: 7027827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serratus Anterior Muscle Pain Syndrome: A Diagnostic Conundrum.
    Bautista A; Webb C; Rosenquist R
    Pain Med; 2017 Aug; 18(8):1600-1602. PubMed ID: 28339634
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigger point injections vs. jet injection in the treatment of myofascial pain.
    Ready LB; Kozody R; Barsa JE; Murphy TM
    Pain; 1983 Feb; 15(2):201-6. PubMed ID: 6844028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-spinal headache.
    Dunteman E; Turner MS; Swarm R
    Reg Anesth; 1996; 21(4):358-60. PubMed ID: 8837197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL; Gray DS; Burnham RS
    Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection in the cervical facet joint for shoulder pain with myofascial trigger points in the upper trapezius muscle.
    Tsai CT; Hsieh LF; Kuan TS; Kao MJ; Hong CZ
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with failure of trigger point injections.
    Hopwood MB; Abram SE
    Clin J Pain; 1994 Sep; 10(3):227-34. PubMed ID: 7833581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of myofascial trigger point injections are naloxone reversible.
    Fine PG; Milano R; Hare BD
    Pain; 1988 Jan; 32(1):15-20. PubMed ID: 3340420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study.
    Ketenci A; Basat H; Esmaeilzadeh S
    Agri; 2009 Jul; 21(3):95-103. PubMed ID: 19780000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofascial pain syndrome in the differential diagnosis of chronic abdominal pain.
    Cimen A; Celik M; Erdine S
    Agri; 2004 Jul; 16(3):45-7. PubMed ID: 15382004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibromyalgia and trigger points].
    Pippa P; Allegra A; Cirillo L; Doni L; Rivituso C
    Minerva Anestesiol; 1994 May; 60(5):281-3. PubMed ID: 7936345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a myofascial trigger point injection for groin pain in patients with chronic prostatitis/chronic pelvic pain syndrome: a pilot study.
    Kim DS; Jeong TY; Kim YK; Chang WH; Yoon JG; Lee SC
    Arch Phys Med Rehabil; 2013 May; 94(5):930-6. PubMed ID: 23262156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.